This World Breast Cancer Research Day, the Alliance for Clinical Trials in Oncology is highlighting the importance of clinical research in advancing better treatments and improving early detection to ...

Spevatamig is a bispecific antibody targeting claudin 18.2 and CD47, designed to function as an innate immunity enhancer.

Phanes Therapeutics, Inc. (Phanes), a clinical stage biotech company focused on innovative drug discovery and development in oncology, has expanded their clinical trial collaboration with Merck (known ...

Eikon announced seven abstracts accepted for presentation at the European Society for Medical Oncology (ESMO) Congress 2026 highlighting progress ...

Pliant Therapeutics, Inc. (Nasdaq: PLRX) today announced the receipt of Fast Track designation from the U.S. Food and Drug Administration (FDA) for PLN-101095, an oral, small molecule, dual selective ...

Planning to submit a Biologics License Application (BLA) for aglatimagene besadenovec (aglatimagene) in localized, intermediate- to high-risk ...

While it discontinued the Phase III trial, AstraZeneca did announce two NSCLC successes with other oncology assets.

"PD-L1 is clinically useful but imperfect," expert says ...

Investigators compared rates of pathologic response for neoadjuvant immunotherapy and neoadjuvant chemoimmunotherapy in patients with resectable HNSCC treated in an off-trial setting.

US-based clinical-stage biopharmaceutical company Bicara Therapeutics is expecting its lead drug candidate, a potential first-in-class innovative cancer medicine, to enter a critical phase of clinical ...

Unlike antibody drug conjugates, KJ‑103 does not contain a cytotoxic payload. It recruits immune cells to kill tumour cells ...